Skip to Main Content

Paper Details

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity.
Cell
112
2021
DNA, MHC I, RNA, T cells, cancer, cancer cells, tumor, tumor MHC class I, tumor types
Author NameAffiliation
Benjamin D GreenbaumMemorial Sloan Kettering Cancer Center
Andrew ChowMemorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy
Arnab GhoshMemorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy
Abigail XieWeill Cornell Medical School
Eric WangMemorial Sloan Kettering Cancer Center
Jian JinMount Sinai Center for Therapeutics Discovery, Departments of Pharmacological Sciences and Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Henrik MolinaThe Rockefeller University
Robert K BradleyFred Hutchinson Cancer Research Center, University of Washington
  • 1 - 8

Datasets